The routine commissioning of lisdexamfetamine is accepted in Devon for the treatment of attention deficit hyperactivity disorder (ADHD) in adults who have failed to gain an adequate response to, or tolerate, methylphenidate.
Please note there is a separate policy for lisdexamfetamine for ADHD in children and adolescents.
| Filename: | Lisdexamfetamine for the management of attention deficit hyperactivity disorder (ADHD) in adults |
| Filetype: | |
| Filesize: | 90.26 KB |
| Date uploaded: | 15th July 2021 |
| Date updated: | 8th December 2022 |
